These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [The Italian SurveY on carDiac rEhabilitation 2008 (ISYDE 2008): study presentation]. Tramarin R; Ambrosetti M; De Feo S; Griffo R; Maslowsky F; Diaco T; ; Piepoli M; Riccio C G Ital Cardiol (Rome); 2008 Jul; 9(7):497-503. PubMed ID: 18678216 [TBL] [Abstract][Full Text] [Related]
3. Benefits of risk factor modification through cardiac rehabilitation. Borrás IC; Cruz-Jiménez M; Nadal E; Middelhoff A; Rivera A Bol Asoc Med P R; 2008; 100(4):75-9. PubMed ID: 19400532 [TBL] [Abstract][Full Text] [Related]
4. [Heart groups in Germany-current situation and prospects]. Bjarnason-Wehrens B; Held K; Karoff M Herz; 2006 Sep; 31(6):559-65. PubMed ID: 17036187 [TBL] [Abstract][Full Text] [Related]
5. Re-engineering cardiac rehabilitation programmes: considering the patient's point of view. Pâquet M; Bolduc N; Xhignesse M; Vanasse A J Adv Nurs; 2005 Sep; 51(6):567-76. PubMed ID: 16129007 [TBL] [Abstract][Full Text] [Related]
6. Principles for national and regional guidelines on cardiovascular disease prevention: a scientific statement from the World Heart and Stroke Forum. Smith SC; Jackson R; Pearson TA; Fuster V; Yusuf S; Faergeman O; Wood DA; Alderman M; Horgan J; Home P; Hunn M; Grundy SM Circulation; 2004 Jun; 109(25):3112-21. PubMed ID: 15226228 [No Abstract] [Full Text] [Related]
7. [When should we start the treatment of the cardiovascular risk factors]. de Berrazueta Fernández JR An R Acad Nac Med (Madr); 2008; 125(1):125-36; discussion 136-44. PubMed ID: 18777847 [TBL] [Abstract][Full Text] [Related]
8. [Cardiac rehabilitation. Its historical evolution and current situation]. Velasco Rami JA; Maroto Montero JM Rev Esp Cardiol; 1995; 48 Suppl 1():1-7. PubMed ID: 7644814 [TBL] [Abstract][Full Text] [Related]
15. Achievement of secondary preventive goals after acute myocardial infarction: a comparison between participants and nonparticipants in a routine patient education program in Sweden. Bellman C; Hambraeus K; Lindbäck J; Lindahl B J Cardiovasc Nurs; 2009; 24(5):362-8. PubMed ID: 19652617 [TBL] [Abstract][Full Text] [Related]
16. The heart of the matter: reducing CVD risk. Hayman LL; Kamau MW; Stuart-Shor EM Nurse Pract; 2009 May; 34(5):30-5. PubMed ID: 19390396 [No Abstract] [Full Text] [Related]
17. Toward optimal health: the experts discuss cardiovascular disease. Interviewed by Jodi R. Godfrey. Bairey Merz CN; Hayes SN J Womens Health (Larchmt); 2005; 14(1):4-10. PubMed ID: 15692270 [No Abstract] [Full Text] [Related]
18. The importance of managing cardiovascular risk in the treatment of hypertension: the role of ACE inhibitors and ARBs. Pierson CA; Epstein BJ; Roberts ME J Am Acad Nurse Pract; 2008 Nov; 20(11):529-38. PubMed ID: 19128336 [No Abstract] [Full Text] [Related]
20. Secondary prevention of cardiovascular disease in different primary healthcare systems with and without pay-for-performance. Cupples ME; Byrne MC; Smith SM; Leathem CS; Murphy AW Heart; 2008 Dec; 94(12):1594-600. PubMed ID: 18701532 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]